What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
Matthew D. Breyer spends much of his time researching Internal medicine, Endocrinology, Receptor, Renal function and Cyclooxygenase.
Kidney, Prostaglandin E, Renal physiology, Kidney disease and Macula densa are subfields of Internal medicine in which his conducts study.
His Macula densa research includes themes of Renal glomerulus and Renal cortex.
His research integrates issues of Peroxisome proliferator-activated receptor and Nephrology in his study of Endocrinology.
His work on Prostaglandin E2 receptor as part of general Receptor research is frequently linked to Class C GPCR, bridging the gap between disciplines.
His Renal function study integrates concerns from other disciplines, such as Nitric oxide synthase, Glomerular basement membrane, Inulin and Streptozotocin.
His most cited work include:
- Prostanoid receptors: subtypes and signaling. (852 citations)
- Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. (794 citations)
- Mouse Models of Diabetic Nephropathy (718 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Endocrinology, Kidney, Receptor and Diabetic nephropathy.
His Internal medicine research integrates issues from Gene expression and Eicosanoid.
As a member of one scientific family, Matthew D. Breyer mostly works in the field of Endocrinology, focusing on Cyclooxygenase and, on occasion, Renal cortex.
His Kidney research incorporates elements of Renin–angiotensin system, Macula densa, Pharmacology and In situ hybridization.
His Receptor research incorporates themes from Molecular biology and Signal transduction.
Matthew D. Breyer interconnects Nephropathy, Disease, Immunology and Glomerular basement membrane in the investigation of issues within Diabetic nephropathy.
He most often published in these fields:
- Internal medicine (75.82%)
- Endocrinology (72.53%)
- Kidney (32.97%)
What were the highlights of his more recent work (between 2010-2021)?
- Internal medicine (75.82%)
- Kidney disease (14.84%)
- Albuminuria (13.19%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Kidney disease, Albuminuria, Disease and Diabetic nephropathy.
His work on Internal medicine is being expanded to include thematically relevant topics such as Endocrinology.
His study in the fields of Kidney and Prostaglandin E2 under the domain of Endocrinology overlaps with other disciplines such as Mean arterial pressure.
His Kidney disease study incorporates themes from Patient satisfaction, Nephrology, Clinical trial, Oncology and Immunology.
Matthew D. Breyer works mostly in the field of Disease, limiting it down to concerns involving Diabetic kidney and, occasionally, Creatinine, Nephron and TGF alpha.
His Diabetic nephropathy research is multidisciplinary, incorporating perspectives in Disease pathogenesis, Therapeutic trial, Oxidative injury and Intensive care medicine.
Between 2010 and 2021, his most popular works were:
- The next generation of therapeutics for chronic kidney disease (120 citations)
- Circulating αKlotho influences phosphate handling by controlling FGF23 production. (117 citations)
- Prostaglandin E2-Mediated Attenuation of Mesocortical Dopaminergic Pathway Is Critical for Susceptibility to Repeated Social Defeat Stress in Mice (82 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
His primary areas of study are Internal medicine, Diabetic nephropathy, Kidney disease, Endocrinology and Disease.
Many of his research projects under Internal medicine are closely connected to Public attention, Redress and Osteomalacia with Public attention, Redress and Osteomalacia, tying the diverse disciplines of science together.
His work carried out in the field of Diabetic nephropathy brings together such families of science as Pathology, Albuminuria, Renal function and Type 2 diabetes.
His Kidney disease study combines topics in areas such as Patient satisfaction, Nephrology and Clinical trial.
Endocrinology is often connected to Prostaglandin E2 receptor in his work.
His research investigates the connection between Disease and topics such as Fibrosis that intersect with problems in Inflammation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
